Investigation of a Novel Cosmeceutical to Reduce the Visible Signs of Cutaneous Aging (REDUCEAGE)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02877758|
Recruitment Status : Unknown
Verified August 2016 by Tomorrowlabs GmbH.
Recruitment status was: Not yet recruiting
First Posted : August 24, 2016
Last Update Posted : August 25, 2016
|Condition or disease||Intervention/treatment||Phase|
|Aging||Other: Tomorrowlabs cosmeceutical formulation Other: Sham cosmeceutical formulation||Phase 1 Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||40 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Triple (Participant, Care Provider, Outcomes Assessor)|
|Official Title:||Investigation of a Novel Cosmeceutical to Reduce the Visible Signs of Cutaneous Aging - A Randomized Controlled Double Blind Study|
|Study Start Date :||September 2016|
|Estimated Primary Completion Date :||February 2017|
|Estimated Study Completion Date :||February 2017|
Tomorrowlabs cosmeceutical formulation is applied to the face of the subjects twice daily for 3 consecutive months.
Other: Tomorrowlabs cosmeceutical formulation
Sham Comparator: Control
Tomorrowlabs cosmeceutical formulation without the active ingredient is applied to the face of the subjects twice daily for 3 consecutive months.
Other: Sham cosmeceutical formulation
- Validated Assessment Scales for Age-related Changes of the Face [ Time Frame: 3 months ]A reliable tool for valid and reproducible assessment of the aging process in various face areas will be employed by our independent panel of assessors to scale the primary outcome. (1-3)
- Skin quality assessment [ Time Frame: 3 months ]The skin scope uses black light and magnification to show variety of skin imperfections that are undetectable with the naked eye such as dry and thin skin
- Subject Satisfaction With the Results [ Time Frame: 3 months ]Self assessment questionnaire
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02877758
|Contact: Dominik Thor, PhDemail@example.com|
|Principal Investigator:||Raphael Wenny, MD||JKU|